Clonal Dissemination of Candida auris Clinical Isolates in Northern Italy, 2021.

IF 2.3 4区 医学 Q3 INFECTIOUS DISEASES
Microbial drug resistance Pub Date : 2024-01-01 Epub Date: 2023-10-17 DOI:10.1089/mdr.2023.0150
Stefano Amadesi, Marta Palombo, Federica Bovo, Andrea Liberatore, Elena Vecchi, Monica Cricca, Tiziana Lazzarotto, Simone Ambretti, Paolo Gaibani
{"title":"Clonal Dissemination of <i>Candida auris</i> Clinical Isolates in Northern Italy, 2021.","authors":"Stefano Amadesi, Marta Palombo, Federica Bovo, Andrea Liberatore, Elena Vecchi, Monica Cricca, Tiziana Lazzarotto, Simone Ambretti, Paolo Gaibani","doi":"10.1089/mdr.2023.0150","DOIUrl":null,"url":null,"abstract":"<p><p><i>Candida auris</i> is a concerning pathogen in health care due to its ability to spread in medical settings. In this study, we characterized the genome of three <i>C. auris</i> clinical isolates collected in the Emilia-Romagna region of Northeastern Italy from January 2020 to May 2021. Whole-genome sequencing was performed using Illumina iSeq 100 and Oxford Nanopore MinION systems. Genomes were assembled with Flye. Phylogenetic analysis was carried out with RaxML. The ERG<i>11</i>, <i>TAC1b</i>, and <i>FKS1</i> genes were examined for known substitutions associated with resistance to azoles and caspofungin using Diamond. All three <i>C. auris</i> isolates belonged to clade I (South Asian lineage) and showed high minimum inhibitory concentrations for fluconazole. Two of the three isolates were closely related to the first Italian index case of <i>C. auris</i> occurred in the 2019 and carried similar mutations associated to azole resistance. The third isolate showed a greater phylogenetic distance from these strains and had a different genetic determinant not previously seen in Italy. Our data suggest that two <i>C. auris</i> clinical isolates may have been epidemiologically related to the first outbreak previously observed in Italy, while the remaining isolate may have originated from a different source. Further research is needed to understand <i>C. auris</i> transmission and resistance and to control its spread.</p>","PeriodicalId":18701,"journal":{"name":"Microbial drug resistance","volume":" ","pages":"50-54"},"PeriodicalIF":2.3000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Microbial drug resistance","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1089/mdr.2023.0150","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/10/17 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Candida auris is a concerning pathogen in health care due to its ability to spread in medical settings. In this study, we characterized the genome of three C. auris clinical isolates collected in the Emilia-Romagna region of Northeastern Italy from January 2020 to May 2021. Whole-genome sequencing was performed using Illumina iSeq 100 and Oxford Nanopore MinION systems. Genomes were assembled with Flye. Phylogenetic analysis was carried out with RaxML. The ERG11, TAC1b, and FKS1 genes were examined for known substitutions associated with resistance to azoles and caspofungin using Diamond. All three C. auris isolates belonged to clade I (South Asian lineage) and showed high minimum inhibitory concentrations for fluconazole. Two of the three isolates were closely related to the first Italian index case of C. auris occurred in the 2019 and carried similar mutations associated to azole resistance. The third isolate showed a greater phylogenetic distance from these strains and had a different genetic determinant not previously seen in Italy. Our data suggest that two C. auris clinical isolates may have been epidemiologically related to the first outbreak previously observed in Italy, while the remaining isolate may have originated from a different source. Further research is needed to understand C. auris transmission and resistance and to control its spread.

耳念珠菌临床分离株在意大利北部的克隆传播,2021。
耳念珠菌由于其在医疗环境中传播的能力,在医疗保健中是一种令人担忧的病原体。在这项研究中,我们对2020年1月至2021年5月在意大利东北部艾米利亚-罗马涅地区采集的三株金黄色葡萄球菌临床分离株的基因组进行了表征。使用Illumina iSeq 100和Oxford Nanopore Mineion系统进行全基因组测序。基因组与Flye组装在一起。用RaxML进行系统发育分析。使用Diamond检测ERG11、TAC1b和FKS1基因是否存在与唑类和卡泊芬净耐药性相关的已知取代。所有三个金黄色葡萄球菌分离株均属于分支I(南亚谱系),对氟康唑的最低抑制浓度较高。三个分离株中的两个与2019年发生的第一例意大利金黄色葡萄球菌指数病例密切相关,并携带与唑类耐药性相关的类似突变。第三个分离株显示出与这些菌株更大的系统发育距离,并且具有以前在意大利没有发现的不同的遗传决定簇。我们的数据表明,两个金黄色葡萄球菌临床分离株可能与之前在意大利观察到的第一次疫情有关,而其余分离株可能来自不同的来源。需要进一步的研究来了解金黄色葡萄球菌的传播和耐药性,并控制其传播。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Microbial drug resistance
Microbial drug resistance 医学-传染病学
CiteScore
6.00
自引率
3.80%
发文量
118
审稿时长
6-12 weeks
期刊介绍: Microbial Drug Resistance (MDR) is an international, peer-reviewed journal that covers the global spread and threat of multi-drug resistant clones of major pathogens that are widely documented in hospitals and the scientific community. The Journal addresses the serious challenges of trying to decipher the molecular mechanisms of drug resistance. MDR provides a multidisciplinary forum for peer-reviewed original publications as well as topical reviews and special reports. MDR coverage includes: Molecular biology of resistance mechanisms Virulence genes and disease Molecular epidemiology Drug design Infection control.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信